Results 31 to 40 of about 4,575 (215)

ORAL TOPICAL TIMOLOL MALEAT OR ORAL PROPRANOLOL TREATMENT FOR INFANTILE HEMANGIOMAS: CLINICAL ANALYSIS OF 403 PATIENTS [PDF]

open access: yesSanamed, 2023
Objective: Infantile hemangiomas (IH) are the most common benign vascular tumors of infancy. Propranolol (P), a nonselective beta-blocker, has been successfully used in managing IHs.
Terzi Özlem   +9 more
doaj   +1 more source

Alteração do filme lacrimal e superfície ocular em usuários crônicos de medicação antiglaucomatosa [PDF]

open access: yes, 2008
PURPOSE: Tear film can be altered by chronic medications that may disrupt the equilibrium responsible for the functioning of the lacrimal gland and ocular surface.
BAFFA, Lina do Prado   +7 more
core   +2 more sources

Treatment patterns and outcomes in children with infantile hemangiomas: A retrospective observational analysis

open access: yesSAGE Open Medicine, 2021
Objective: This study aimed to make use of real-world medical records to explore the clinical characteristics, treatments, and outcomes of infantile hemangiomas in southeastern China. Methods: This study applied a retrospective observational method using
Yantao Cai   +6 more
doaj   +1 more source

Electrically atomised formulations of timolol maleate for direct and on-demand ocular lens coatings [PDF]

open access: yes, 2017
The file attached to this record is the author's final peer reviewed version.
Ahmad, Zeeshan   +6 more
core   +2 more sources

Efficacy and safety of timolol maleate/latanoprost fixed combination versus timolol maleate and brimonidine given twice daily [PDF]

open access: yesActa Ophthalmologica Scandinavica, 2003
Abstract.Purpose:  To evaluate the efficacy and safety of the timolol maleate/latanoprost fixed combination (TLFC) given once each evening versus brimonidine and timolol solution given twice daily as concomitant therapy in primary open‐angle glaucoma or ocular hypertension patients.Methods:  Qualified subjects were begun on timolol alone twice daily ...
William C, Stewart   +3 more
openaire   +2 more sources

Changes in visual function after intraocular pressure reduction using antiglaucoma medications [PDF]

open access: yes, 2009
Purpose To evaluate the change in visual function after starting glaucoma treatment and correlate this to a decrease in intraocular pressure (IOP) in primary open-angle glaucoma patients.Methods A prospective, randomized clinical trial was carried out ...
A Harris   +22 more
core   +2 more sources

Current Knowledge and Attitudes Concerning Cost-Effectiveness in Glaucoma Pharmacotherapy: A Glaucoma Specialists Focus Group Study. [PDF]

open access: yes, 2020
Background:Rising healthcare costs motivate continued cost-reduction efforts. To help lower costs associated with open-angle glaucoma (OAG), a prevalent, progressive disease with substantial direct and indirect costs, clinicians need to understand the ...
Cioffi, George A   +4 more
core  

Safety and efficacy of travoprost solution for the treatment of elevated intraocular pressure [PDF]

open access: yes, 2015
Travoprost is a prostaglandin analogue widely used for reducing intraocular pressure (IOP) in patients affected with glaucoma and ocular hypertension. It exerts its ocular hypotensive effect through the prostaglandin FP receptors, located in the ciliary ...
Centofanti, Marco   +5 more
core   +2 more sources

Effect of dacryocystorhinostomy on systemic adverse effects of topical timolol maleate

open access: yesIndian Journal of Ophthalmology, 2012
Purpose: To evaluate whether transformation of the naso-lacrimal passage as happens after dacryocystorhinostomy (DCR) operation has any effect on the systemic adverse effects of topically administered timolol maleate.
Kakoli Roy   +5 more
doaj   +1 more source

Ulcerated Infantile Hemangioma of the Intergluteal Cleft Treated with Topical Timolol [PDF]

open access: yes, 2013
Dados recentes revelam resultados promissores com a utilização de beta-bloqueante tópico no tratamento dos hemangiomas infantis ulcerados. Os autores descrevem o caso clínico de uma lactente pré-termo de 6 meses de idade com um hemangioma infantil ...
Amaro, C, Cardoso, J, Fernandes, S
core   +2 more sources

Home - About - Disclaimer - Privacy